Anti-IL-17 Antibody Improves Hepatic Steatosis by Suppressing Interleukin-17-Related Fatty Acid Synthesis and Metabolism
Figure 7
The effect of an intravenous dose of 1 μg of IL-17 on the transcript levels for the four selected proteins in vivo. The expression levels of SREBP-1c, ChREBP, ECHS1, and PPAR-α mRNA were determined in livers collected 16 hours after being intravenously injected with IL-17. Gene expression levels in mice from the control group were set at 1. The data indicate Mean ± SEM of three separate experiments. ; ; .
